88 related articles for article (PubMed ID: 6616998)
1. Is the growth of breast carcinoma regulated by the axillary nodes?
Hartveit F; Tangen M; Halvorsen JF
Clin Oncol; 1983 Sep; 9(3):239-44. PubMed ID: 6616998
[TBL] [Abstract][Full Text] [Related]
2. Predictors of non-sentinel lymph node metastasis in breast cancer patients.
Goyal A; Douglas-Jones A; Newcombe RG; Mansel RE;
Eur J Cancer; 2004 Jul; 40(11):1731-7. PubMed ID: 15251163
[TBL] [Abstract][Full Text] [Related]
3. Metastases to the upper levels of the axillary nodes in carcinoma of the breast and its implications for nodal sampling procedures.
Pigott J; Nichols R; Maddox WA; Balch CM
Surg Gynecol Obstet; 1984 Mar; 158(3):255-9. PubMed ID: 6701738
[TBL] [Abstract][Full Text] [Related]
4. Micrometastases to the axilla in breast cancer: their size and season of presentation.
Hartveit F
Invasion Metastasis; 1996; 16(3):144-9. PubMed ID: 9186549
[TBL] [Abstract][Full Text] [Related]
5. Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma.
Krishnamurthy S; Sneige N; Bedi DG; Edieken BS; Fornage BD; Kuerer HM; Singletary SE; Hunt KK
Cancer; 2002 Sep; 95(5):982-8. PubMed ID: 12209680
[TBL] [Abstract][Full Text] [Related]
6. [Management of the axilla in breast cancer: evidences and unresolved issues].
Fodor J; Polgár C; Péley G; Németh G
Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
[TBL] [Abstract][Full Text] [Related]
7. Distribution of mast cells in the axillary lymph nodes of breast cancer patients.
Naik R; Baliga P; Bansal R; Pai M
J Indian Med Assoc; 1997 Dec; 95(12):606-7. PubMed ID: 9586403
[TBL] [Abstract][Full Text] [Related]
8. Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?
Specht MC; Fey JV; Borgen PI; Cody HS
J Am Coll Surg; 2005 Jan; 200(1):10-4. PubMed ID: 15631914
[TBL] [Abstract][Full Text] [Related]
9. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
11. Axillary node histology in cases of infiltrating breast cancer without nodal metastases dying later of disseminated disease.
Hartveit F
Invest Cell Pathol; 1980; 3(3):311-4. PubMed ID: 7429886
[TBL] [Abstract][Full Text] [Related]
12. [Identification of the sentinel node in patients with breast carcinoma].
Nieweg OE; Kapteijn BA; Peterse JL; Rutgers EJ; van Dongen JA; Kroon BB
Ned Tijdschr Geneeskd; 1996 Nov; 140(45):2235-9. PubMed ID: 8984369
[TBL] [Abstract][Full Text] [Related]
13. Determinants of axillary recurrence after axillary lymph node dissection for invasive breast cancer.
Voogd AC; de Boer R; van der Sangen MJ; Roumen RM; Rutten HJ; Coebergh JW
Eur J Surg Oncol; 2001 Apr; 27(3):250-5. PubMed ID: 11373100
[TBL] [Abstract][Full Text] [Related]
14. Breast carcinoma grading, estimation of tumor size, axillary lymph node status, staging, and nottingham prognostic index scoring on mastectomy specimens.
Ahmad Z; Khurshid A; Qureshi A; Idress R; Asghar N; Kayani N
Indian J Pathol Microbiol; 2009; 52(4):477-81. PubMed ID: 19805950
[TBL] [Abstract][Full Text] [Related]
15. The impact of axillary lymph nodes removed in staging of node-positive breast carcinoma.
Kuru B; Bozgul M
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1328-34. PubMed ID: 16997505
[TBL] [Abstract][Full Text] [Related]
16. Axillary nodal metastasis of occult breast primary cancer.
Tamiolakis D; Antoniou C
Chirurgia (Bucur); 2008; 103(4):467-71. PubMed ID: 18780622
[TBL] [Abstract][Full Text] [Related]
17. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ
Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492
[TBL] [Abstract][Full Text] [Related]
18. Axillary and extra-axillary lymph node recurrences after a tumor-negative sentinel node biopsy for breast cancer using intralesional tracer administration.
van der Ploeg IM; Kroon BB; Antonini N; Valdés Olmos RA; Rutgers EJ; Nieweg OE
Ann Surg Oncol; 2008 Apr; 15(4):1025-31. PubMed ID: 18219534
[TBL] [Abstract][Full Text] [Related]
19. Node-positive breast cancer: axillary micrometastases, their incidence and some implications.
Hartveit F
Invasion Metastasis; 1996; 16(6):317-21. PubMed ID: 9371231
[TBL] [Abstract][Full Text] [Related]
20. Extranodal extension of axillary metastasis of invasive breast carcinoma as a possible predictor for the total number of positive lymph nodes.
Palamba HW; Rombouts MC; Ruers TJ; Klinkenbijl JH; Wobbes T
Eur J Surg Oncol; 2001 Dec; 27(8):719-22. PubMed ID: 11735167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]